CSW Stock Analysis: CSW Industrials | NYSE
Specialty Industrial Machinery | NYSE, USA | Market Cap: 5.378m USD | 12M Return: 24.4% | US1264021064 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 46.8M
EPS Trend: 96.9%
Qual. Beats: 0
Rev. Trend: 96.9%
Warnings
Tailwinds
Seasonality 10.8 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
CSW Industrials, Inc. is a Dallas-based industrial products company incorporated in 2014 that operates across the Americas, Europe, the Middle East and Africa, and the Asia Pacific. The company is organized into three reporting segments: Contractor Solutions, which supplies HVAC, plumbing, and electrical installation products; Engineered Building Solutions, which provides architectural and fire-protection building components; and Specialized Reliability Solutions, which offers industrial maintenance compounds, lubricants, sealants, and filtration products. CSW Industrials sells its products under a large portfolio of owned brands, including RectorSeal, Falcon, Balco, Jet-Lube, and OilSafe.
The company is classified within the GICS Industrials sector, specifically the Building Products sub-industry, reflecting its mix of HVAC, plumbing, and architectural building components. Its business model relies on a multi-brand, multi-channel distribution approach, selling specialty products to contractors, commercial building developers, and industrial maintenance customers rather than serving as a single-product manufacturer.
- HVAC demand and construction cycle drive Contractor Solutions revenue
- Acquisition strategy expands margins and product portfolio across segments
- Industrial maintenance spending lifts Specialized Reliability Solutions segment
| Net Income: 120.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -3.60 > 1.0 |
| NWC/Revenue: 33.16% < 20% (prev 32.01%; Δ 1.15% < -1%) |
| CFO/TA 0.07 > 3% & CFO 164.6m > Net Income 120.9m |
| Net Debt (883.4m) to EBITDA (281.1m): 3.14 < 3 |
| Current Ratio: 2.70 > 1.5 & < 3 |
| Outstanding Shares: last quarter (16.4m) vs 12m ago -2.93% < -2% |
| Gross Margin: 42.38% > 18% (prev 43.82%; Δ -1.45% > 0.5%) |
| Asset Turnover: 60.45% > 50% (prev 59.62%; Δ 0.83% > 0%) |
| Interest Coverage Ratio: 6.11 > 6 (EBIT TTM 207.4m / Interest Expense TTM 34.0m) |
| A: 0.17 (Total Current Assets 616.0m - Total Current Liabilities 228.1m) / Total Assets 2.33b |
| B: 0.36 (Retained Earnings 843.8m / Total Assets 2.33b) |
| C: 0.11 (EBIT TTM 207.4m / Avg Total Assets 1.93b) |
| D: 0.87 (Book Value of Equity 1.07b / Total Liabilities 1.24b) |
| Altman-Z'' = 3.90 = AA |
| DSRI: 1.02 (Receivables 233.3m/179.4m, Revenue 1.17b/915.8m) |
| GMI: 1.03 (GM 43.82% / 42.38%) |
| AQI: 1.16 (AQ_t 0.69 / AQ_t-1 0.59) |
| SGI: 1.28 (Revenue 1.17b / 915.8m) |
| TATA: -0.02 (NI 120.9m - CFO 164.6m) / TA 2.33b) |
| Beneish M = -2.69 (Cap -4..+1) = A |
As of August 24, 2026, the stock is trading at USD 330.09 with a total of 74,833 shares traded. Over the past week, the price has changed by -4.36%, over one month by +13.82%, over three months by +18.18% and over the past year by +24.37%.
Current recommended Stop Loss: 299.50 (which is 9.3% or 2.5 ATR below the current price).
CSW Industrials has received a consensus analysts rating of 3.20. Therefore, it is recommended to hold CSW.
- StrongBuy: 0
- Buy: 1
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 351.9 | 6.6% |
P/E Trailing = 45.2798
P/E Forward = 42.5532
P/S = 4.5986
P/B = 5.0096
P/EG = 2.8426
Revenue TTM = 1.17b USD
EBIT TTM = 207.4m USD
EBITDA TTM = 281.1m USD
Long Term Debt = 826.0m USD (from longTermDebt, last quarter)
Short Term Debt = 29.5m USD (from shortTermDebt, last quarter)
Debt = 930.9m USD (from shortLongTermDebtTotal, last quarter) + Leases 75.5m
Net Debt = 883.4m USD (calculated: Debt 930.9m - CCE 47.5m)
Enterprise Value = 6.26b USD (5.38b + Debt 930.9m - CCE 47.5m)
Interest Coverage Ratio = 6.11 (Ebit TTM 207.4m / Interest Expense TTM 34.0m)
EV/FCF = 43.40x (Enterprise Value 6.26b / FCF TTM 144.3m)
FCF Yield = 2.30% (FCF TTM 144.3m / Enterprise Value 6.26b)
FCF Margin = 12.34% (FCF TTM 144.3m / Revenue TTM 1.17b)
Net Margin = 10.33% (Net Income TTM 120.9m / Revenue TTM 1.17b)
Gross Margin = 42.38% ((Revenue TTM 1.17b - Cost of Revenue TTM 674.0m) / Revenue TTM)
Gross Margin QoQ = 44.88% (prev 40.98%)
Tobins Q-Ratio = 2.68 (Enterprise Value 6.26b / Total Assets 2.33b)
Interest Expense / Debt = 3.65% (Interest Expense 34.0m / Debt 930.9m)
Taxrate = 23.17% (36.6m / 158.1m)
NOPAT = 159.4m (EBIT 207.4m * (1 - 23.17%))
Current Ratio = 2.70 (Total Current Assets 616.0m / Total Current Liabilities 228.1m)
Debt / Equity = 0.87 (Debt 930.9m / totalStockholderEquity, last quarter 1.07b)
Debt / EBITDA = 3.14 (Net Debt 883.4m / EBITDA 281.1m)
Debt / FCF = 6.12 (Net Debt 883.4m / FCF TTM 144.3m)
Total Stockholder Equity = 1.08b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.25% (Net Income 120.9m / Total Assets 2.33b)
RoE = 11.19% (Net Income TTM 120.9m / Total Stockholder Equity 1.08b)
RoCE = 10.88% (EBIT 207.4m / Capital Employed (Equity 1.08b + L.T.Debt 826.0m))
RoIC = 7.64% (NOPAT 159.4m / Invested Capital 2.09b)
WACC = 10.47% (E(5.38b)/V(6.31b) * Re(11.80%) + D(930.9m)/V(6.31b) * Rd(3.65%) * (1-Tc(0.23)))
Discount Rate = 11.80% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 68.08 | Cagr: 2.19%
[DCF] Terminal Value 67.71% ; FCFF base≈146.7m ; Y1≈142.4m ; Y5≈140.9m
[DCF] Fair Price = 45.57 (EV 1.63b - Net Debt 883.4m = Equity 742.6m / Shares 16.3m; r=10.47% [WACC]; 5y FCF grow -4.00% → 2.50% )
EPS Correlation: 96.88 | EPS CAGR: 22.00% | SUE: 0.46 | # QB: 0
Revenue Correlation: 96.91 | Revenue CAGR: 15.49% | SUE: N/A | # QB: 0
EPS current Quarter (2026-09-30): EPS=3.63 | Chg30d=+4.86% | Revisions=+30% | Analysts=7
EPS next Quarter (2026-12-31): EPS=1.84 | Chg30d=+0.50% | Revisions=-10% | Analysts=7
EPS current Year (2027-03-31): EPS=12.59 | Chg30d=+4.63% | Revisions=+50% | GrowthEPS=+21.3% | GrowthRev=+18.5%
EPS next Year (2028-03-31): EPS=13.66 | Chg30d=+3.58% | Revisions=+44% | GrowthEPS=+8.5% | GrowthRev=+4.3%
[Analyst] Revisions Ratio: +37% (up=19, down=8)